The TagCloud requires Javascript and Flash Player 9 or better.
Categoriile
- Compania
- Technologia
- Oncologie
- Mutatii K-RAS
- Farmacogenetica
- Consiliere Genetica
- ADtect
- BCtect
- Oncotype DX
- PCA3 pentru cancerul de prostata
- FMF - Febra Mediteraneana Familiala
- Microorganisme
- Virusuri
- Bori Cardiovasculare
- Predispozitie Genetica
- Test de Paternitate
- Neurologie
- Cytometria in Flux
- Identitatea Genetica
- Logistica
- Colaborari
- Certificari
- Directions
Noi servicii
aleator de intrare: ISO 9001:2000
cercetare-publicatii de la Genekor
- Elucidation of the transmission of a novel mutation in BRCA1 (1125delCT) in a family with multiple cases of breast cancer.
- Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
- NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients.
- Culture of primary epithelial adenoma cells from familial adenomatous polyposis patients.
- Inherited cancer predisposition syndromes in Greece.
- The functional polymorphisms of NRAMP1 gene in Greeks with sarcoidosis.
- Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease.
- BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.
- Different intrafamilial clinical presentation of FMF mutation carriers.
- Heterogeneous molecular mechanisms underlie attenuated familial adenomatous polyposis.
ultimele stiri: ASCO (American Society of Clinical Oncology)
- Sirolimus and Temsirolimus for Epithelioid Angiomyolipoma [DIAGNOSIS IN ONCOLOGY]
- Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma During Therapy With Alemtuzumab for T-Cell Prolymphocytic Leukemia [DIAGNOSIS IN ONCOLOGY]
- Isolated Ovarian Relapse in a 68-Year-Old Woman With Acute Lymphoblastic Leukemia [DIAGNOSIS IN ONCOLOGY]
- Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Immunocompetent Woman [DIAGNOSIS IN ONCOLOGY]
- Selection Bias Clouds Apparent Benefit of Longer Hormone Duration [CORRESPONDENCE]
- Reply to K. Lin et al [CORRESPONDENCE]
- Metastatic Disease Response to Treatment: How Many Lesions to Measure? [CORRESPONDENCE]
- Reply to P. Prassopoulos et al [CORRESPONDENCE]
- Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies [CORRESPONDENCE]
- Reply to V. Arena et al [CORRESPONDENCE]
- Revisiting the Concept of Phenotypically Distinct Malignant Pancreatic Stem-Cell Subsets Based on Limiting Dilution Transplantation Assays [CORRESPONDENCE]
- Breast Conservation Treatment With Radiation: An Ongoing Success Story [EDITORIALS]
